MedTech Stocks Q1 Earnings Preview: AXDX, CFMS, SENS
Zacks Investment Research | May 11, 2016 07:31AM ET
With more than 87% of S&P 500 members having reported their Q1 earnings as of May 6, 2016, the overall earnings picture that emerges is quite unimpressive. Macroeconomic and socio-political factors played spoilsport, dealing a blow to crucial sectors in the S&P 500 cohort like Finance, Energy and Technology.
Nevertheless, even in the face of such adversities, Medical retains some sheen (being third among the 16 Zacks sectors in terms of market capitalization) and is expected to post a bright Q1 scorecard. Notably, 79.6% of the medical stocks which have already released earnings have beat earnings while 69.4% topped the revenue estimate. (For more information on this, please check our Zacks Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.